Determining sensitivity of cells to B-Raf inhibitor treatment by detecting Kras mutation and RTK expression levels

Details for Australian Patent Application No. 2010289794 (hide)

Owner GENENTECH, INC.

Inventors Hatzivassiliou, Georgia; Malek, Shiva

Agent Griffith Hack

Pub. Number AU-A-2010289794

PCT Pub. Number WO2011/028540

Priority 61/301,149 03.02.10 US; 61/236,466 24.08.09 US

Filing date 24 August 2010

Wipo publication date 10 March 2011

International Classifications

G01N 33/48 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

Event Publications

5 April 2012 PCT application entered the National Phase

  PCT publication WO2011/028540 Priority application(s): WO2011/028540

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010289795-Forward osmosis membranes

2010289785-Generation of CTL lines with specificity against multiple tumor antigens or multiple viruses